New Regenerative Medicine Center in Clinica de Merida

Regenestem Network and Gilberto Hernandez Falcon, M.D. Open Stem Cell Clinic in Mérida, Yucatán.

Regenestem Network and Global Stem Cells Group announced the grand opening of a new regenerative medicine center in the Hospital Clinica de Mérida in Yucatán, Mexico.

The newest facility in the Regenestem Network will operate under the direction of Gilberto Hernandez Falcon, M.D., CEO of Regenestem Mexico Sur.

Regenestem Network has announced the grand opening of a new stem cells clinic in the prestigious Hospital Clinica de Merida in Yucatan, Mexico. The new clinic will operate under the direction of Gilberto Hernandez Falcon, M.D., a member of the Global Stem Cells Advisory Board and CEO of Regenestem Mexico Sur in Villahermosa Tabasco.

The Yucatan facility is the newest in a growing number of Regenestem clinics providing comprehensive regenerative medicine services worldwide. Plans include equipping the new clinic with the latest technology from the Adilyfe line of stem cell treatment products, made available through Global Stem Cells Group affiliate Adimarket.
“Expanding the Regenestem Network throughout Mexico is a great opportunity to bring cutting edge medical advancements to patients, while creating and sustaining new jobs for medical professionals in the Central America region,” says Regenestem Founder and CEO Ricardo DeCubas. “We’re proud to be working with Dr. Hernandez Falcon in making stem cell medicine available to a growing number of patients in the region.”
The new Regenestem Yucatan facility will offer the most advanced protocols and techniques available in stem cell medicine.

Gilberto Hernandez Falcon, M.D., CEO of Regenestem Mexico Sur (Photo: PRNewswire)


I am proud to continue to provide stem cell therapies to a wide range of patients here in Mexico and the Central America region,” Hernandez Falcon says. “Working with the Regenestem Network and Global Stem Cells Group has allowed us to help more and more patients access promising treatments for a range of medical problems.”

The Global Stem Cells Group and Regenestem are committed to the highest of standards in service and technology, expert and compassionate care, and a philosophy of exceeding the expectations of their international patients.
For more information, visit the Regenestem Network website, email info(at)regenstem(dot)com, or call 305-224-1858.

About Regenestem:

Regenestem Network, a division of the Global Stem Cells Group, Inc., is an international medical practice association committed to researching and producing comprehensive stem cell treatments for patients worldwide. Having assembled a highly qualified staff of medical specialists—professionals trained in the latest cutting-edge techniques in cellular medicine—Regenestem continues to be a leader in delivering the latest protocols in the adult stem cell arena. Global Stem Cells Group and Regenestem Network are expanding the company’s clinical presence worldwide by partnering with experienced and qualified regenerative medicine physicians to open new clinics licensed and developed under the Regenestem banner. In 2014, Global Stem Cells Group expanded the Regenestem Network’s global presence to 20 countries.

Regenestem offers stem cell treatments to help treat a variety of diseases and conditions including arthritis, autism, chronic obstructive pulmonary disease (COPD), diabetes, and pain due to injuries at various facilities worldwide. Regenestem Oaxaca will have an international staff experienced in administering the latest in cellular therapies.

Regenestem is certified for the medical tourism market, and staff physicians are board-certified or board-eligible. Regenestem clinics provide services in more than 10 specialties, attracting patients from the United States and around the world.


About the Global Stem Cell Group:

Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products, and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators, and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
To learn more about Global Stem Cells Group, Inc.’s companies and for investor information, visit the Global Stem Cell Group website.